Grufity logo
Grufity logo
EVLO

EVLO - Evelo Biosciences Inc Stock Price, Fair Value and News

00
Market Closed as of 15 Jun 2026, 04:00 pm ET

Price Targets

EVLO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

EVLO Price Action

EVLO RSI Chart

EVLO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

EVLO Valuation

Market Cap

0

Price/Earnings (Trailing)

0

Price/Sales (Trailing)

0

EV/EBITDA

-0.22

Price/Free Cashflow

0

EVLO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

EVLO Fundamentals

EVLO Revenue

EVLO Earnings

EVLO Profitability

Free Cashflow Yield

0%

EVLO Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
20192.0M2.1M1.6M1.0M
2018---1.6M
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Evelo Biosciences Inc

EVLO
Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis. The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
 CEO
 WEBSITEevelobio.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES66

Evelo Biosciences Inc Frequently Asked Questions

EVLO is the stock ticker symbol of Evelo Biosciences Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Thu May 28 2026, market cap of Evelo Biosciences Inc is 0. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Thu May 28 2026, EVLO's PE ratio (Price to Earnings) is 0 and Price to Sales (PS) ratio is 0. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. EVLO PE ratio will change depending on the future growth rate expectations of investors.